T-cell–redirecting bispecific antibodies in multiple myeloma: a revolution?
Author:
Affiliation:
1. 1Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France; and
2. 2Nantes Université, INSERM, CRCI2NA, Nantes, France
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
https://ashpublications.org/blood/article-pdf/139/26/3681/1904521/bloodbld2021014611c.pdf
Reference65 articles.
1. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma;Mateos;Leukemia.,2022
2. Chimeric antigen receptor T-cells, bispecific antibodies, and antibody-drug conjugates for multiple myeloma: an update;Lakshman;Am J Hematol.,2022
3. Novel immunotherapies in multiple myeloma: chances and challenges;Rasche;Haematologica.,2021
4. Idecabtagene icleucel in relapsed and refractory multiple myeloma;Munshi;N Engl J Med.,2021
5. Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-directed CAR T cell therapy, in relapsed and refractory multiple myeloma: updated KarMMa results;Anderson;J Clin Oncol.,2021
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bispecific Antibodies in the Treatment of Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-01
2. Bispecific Antibodies in Hematological Malignancies: A Scoping Review;Cancers;2023-09-14
3. Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation;Nature Cancer;2023-08-31
4. New Developments in Myeloma Treatment and Response Assessment;Journal of Nuclear Medicine;2023-08-17
5. Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel;Blood Cancer Journal;2023-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3